Cassava Sciences Inc (SAVA NASDAQ) stock market data APIs
$4.1064
-0.23(-5.6%)
as of October 13, 2025
Try our APIs with
free plan!
Cassava Sciences Inc Financial Data Overview
Price chart is built with
Anychart
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
Prev. Close
4.1064
Open
3.8728
High
4.1064
Low
3.8309
52 wk Range
1.15-33.98
Market Cap
181 M
Shares Outstanding
48 308 K
EPS
-0.92
Beta
-0.981
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Cassava Sciences Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Cassava Sciences Inc data using free add-ons & libraries
Get Cassava Sciences Inc Fundamental Data
Cassava Sciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -89 031 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cassava Sciences Inc News
New
How To YieldBoost Toll Brothers From 0.7% To 4.7% Using Options
Shareholders of Toll Brothers Inc. (Symbol: TOL) looking to boost their income beyond the stock's 0.7% annualized dividend yield can sell the January 2028 covered call at the $195 strike and collect t...
Spotlight On Top Penny Stocks In September 2025
As of late September 2025, the U.S. stock market has experienced a downturn, with major indices such as the Dow Jones Industrial Average, S&P 500, and Nasdaq closing lower due to declines in tech stoc...
Biggest stock movers Tuesday: SAVA, CLSK, and more
[Abstract Finance Technology Concept] koto_feja Stock futures inched higher Tuesday premarket as major U.S. indexes hit record highs; investors await Fed Chair Powell’s speech. Here are some of Tu...
Cassava Sciences CEO buys $534K in company stock
* Cassava Sciences (NASDAQ:SAVA [https://seekingalpha.com/symbol/SAVA]) president & CEO Richard Barry has disclosed [https://seekingalpha.com/filing/10438889]a purchase of 237,941 shares of the com...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
